Predict your next investment

SOFTWARE (NON-INTERNET/MOBILE) | Healthcare Software
medventive.com

See what CB Insights has to offer

Total Raised

$31.95M

Investors Count

10

Deal Terms

2

MedVentive Funding, MedVentive Valuation & MedVentive Revenue

9 Fundings

MedVentive's latest funding round was a Acquired for on September 24, 2012.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

9/24/2012

Acquired

1

10/21/2011

Debt

$99M

0

10/21/2011

Series D

$99M

10

5/27/2011

Series C - III

$99M

0

2/19/2010

Series C - II

$99M

0

Date

9/24/2012

10/21/2011

10/21/2011

5/27/2011

2/19/2010

Round

Acquired

Debt

Series D

Series C - III

Series C - II

Amount

$99M

$99M

$99M

$99M

Investors

Valuation

Revenue

Sources

1

0

10

0

0

MedVentive Deal Terms

2 Deal Terms

MedVentive's deal structure is available for 2 funding rounds, including their Series B from May 12, 2008.

Round

Series B

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

MedVentive Investors

10 Investors

MedVentive has 10 investors. McKesson invested in MedVentive's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

9/24/2012

9/24/2012

1
Acquired

Corporation

Texas

10/23/2006

10/21/2011

7
Series C, Series C - II (2010), Series A (2006), Series B (2008), Series C - III (2011), Debt (2011), Series D (2011)

Venture Capital

Massachusetts

7/6/2009

10/21/2011

5
Series C, Series C - II (2010), Series C - III (2011), Debt (2011), Series D (2011)

Mark Levine

Venture Capital

DC

00/00/0000

00/00/0000

Excel Venture Management

Subscribe to see more

Venture Capital

Massachusetts

00/00/0000

00/00/0000

LRVHealth

Subscribe to see more

Venture Capital

Massachusetts

First funding

9/24/2012

10/23/2006

7/6/2009

00/00/0000

00/00/0000

Last Funding

9/24/2012

10/21/2011

10/21/2011

00/00/0000

00/00/0000

Investor

Excel Venture Management

LRVHealth

Rounds

1
Acquired
7
Series C, Series C - II (2010), Series A (2006), Series B (2008), Series C - III (2011), Debt (2011), Series D (2011)
5
Series C, Series C - II (2010), Series C - III (2011), Debt (2011), Series D (2011)

Subscribe to see more

Subscribe to see more

Board Seats

Mark Levine

Type

Corporation

Venture Capital

Venture Capital

Venture Capital

Venture Capital

Location

Texas

Massachusetts

DC

Massachusetts

Massachusetts

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.